Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Debt to Equity (2016 - 2023)

Creative Medical Technology Holdings (CELZ) has disclosed Debt to Equity for 14 consecutive years, with $0.0 as the latest value for Q1 2023.

  • Quarterly Debt to Equity fell 36.89% to $0.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $0.0 through Mar 2023, down 36.89% year-over-year, with the annual reading at $0.0 for FY2022, 35.59% down from the prior year.
  • Debt to Equity for Q1 2023 was $0.0 at Creative Medical Technology Holdings, up from $0.0 in the prior quarter.
  • The five-year high for Debt to Equity was $0.0 in Q1 2022, with the low at -$0.97 in Q4 2020.
  • Average Debt to Equity over 5 years is -$0.3, with a median of -$0.01 recorded in 2020.
  • The sharpest move saw Debt to Equity crashed 51398.73% in 2019, then skyrocketed 109.78% in 2022.
  • Over 5 years, Debt to Equity stood at -$0.85 in 2019, then fell by 14.78% to -$0.97 in 2020, then skyrocketed by 100.14% to $0.0 in 2021, then tumbled by 35.59% to $0.0 in 2022, then grew by 7.04% to $0.0 in 2023.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.0, $0.0, and $0.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.